Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Hoosier Cancer Research Network
Hoosier Cancer Research Network
BicycleTx Limited
Shanghai Junshi Bioscience Co., Ltd.
AstraZeneca
Actuate Therapeutics Inc.
Mirati Therapeutics Inc.
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
AstraZeneca
OHSU Knight Cancer Institute
The First Affiliated Hospital of Guangzhou Medical University
Massachusetts General Hospital
Regeneron Pharmaceuticals
AbbVie
Tempus AI
NovoCure Ltd.
Memorial Sloan Kettering Cancer Center
Institut Bergonié
BeiGene
MedSIR
NYU Langone Health
Bank of Cyprus Oncology Centre
Daiichi Sankyo
Stony Brook University
Elevation Oncology
Incyte Corporation
NeoTX Therapeutics Ltd.
Maastricht University Medical Center
University of Chicago
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Memorial Sloan Kettering Cancer Center
Novartis
Puma Biotechnology, Inc.
NeoImmuneTech
SCRI Development Innovations, LLC
AstraZeneca
pharmaand GmbH
The Methodist Hospital Research Institute
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
G1 Therapeutics, Inc.
WindMIL Therapeutics
National Institutes of Health Clinical Center (CC)
Amgen
Abramson Cancer Center at Penn Medicine
Massachusetts General Hospital
Mereo BioPharma
Clovis Oncology, Inc.
Jonsson Comprehensive Cancer Center
Eli Lilly and Company